Precision Peptide Company Operating Income

Precision Peptide Company (BPC.CN) currently reports a operating income of $-4.7M as of July 2026. That compares with $-1.6M in the prior-year period — down 199.7% year over year. Use the charts on this page to explore Precision Peptide Company's operating income history and peer comparisons.

Precision Peptide Company's operating income decreased from $-1.6M to $-4.7M — a 199.7% year-over-year decrease (period ending July 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Precision Peptide Company reported $-4.7M in operating income as of July 2026. That compares with $-1.6M in the prior-year period — down 199.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-4.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Precision Peptide Company, and consider following BPC.CN for alerts when major investors trade the stock.